Resistance economics: social cost and the evolution of antibiotic resistance

Gardner Brown and David F. Layton

Environment and Development Economics, 1996, vol. 1, issue 3, 349-355

Abstract: Daily and Ehrlich have described the current state of our epidemiological environment in chilling detail. While their point is that human beings interact and affect the epidemiological environment in a variety of ways, the development of antibiotic resistance in bacteria strikes us as one aspect that we can begin to analyse immediately. The evolution of resistance to antibiotics is a function of their use by humans. The more we use, the more selective pressure is placed upon bacteria to develop resistance. This is further complicated by how they are used. Both the duration and the amounts used affect the change in the level of resistance. Finally, the primary feature driving the concern over the use of these drugs is that the evolution of resistance makes these ‘miracle’ drugs exhaustible. We can try to develop new and better antibiotics, but it is uncertain how successful we will be and how expensive they will be if we are successful.

Date: 1996
References: Add references at CitEc
Citations: View citations in EconPapers (34)

Downloads: (external link)
https://www.cambridge.org/core/product/identifier/ ... type/journal_article link to article abstract page (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:cup:endeec:v:1:y:1996:i:03:p:349-355_00

Access Statistics for this article

More articles in Environment and Development Economics from Cambridge University Press Cambridge University Press, UPH, Shaftesbury Road, Cambridge CB2 8BS UK.
Bibliographic data for series maintained by Kirk Stebbing ().